logo
Plus   Neg
Share
Email

EARNINGS SUMMARY: Details of Protalix BioTherapeutics Inc. Q3 Earnings Report

Below are the earnings highlights for Protalix BioTherapeutics Inc. (PLX):

-Earnings: -$3.56 million in Q3 vs. -$5.32 million in the same period last year.
-EPS: -$0.02 in Q3 vs. -$0.04 in the same period last year.
-Revenue: $5.13 million in Q3 vs. $0.66 million in the same period last year.

For comments and feedback contact: editorial@rttnews.com

RELATED NEWS
Follow RTT
>